Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Current Leases (2018 - 2025)

Kiora Pharmaceuticals (KPRX) has disclosed Current Leases for 8 consecutive years, with $155926.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Leases rose 366.19% year-over-year to $155926.0, compared with a TTM value of $155926.0 through Sep 2025, up 366.19%, and an annual FY2024 reading of $23355.0, down 50.38% over the prior year.
  • Current Leases was $155926.0 for Q3 2025 at Kiora Pharmaceuticals, up from $143327.0 in the prior quarter.
  • Across five years, Current Leases topped out at $170056.0 in Q2 2021 and bottomed at $18725.0 in Q3 2023.
  • Average Current Leases over 5 years is $87421.4, with a median of $78040.5 recorded in 2021.
  • The sharpest move saw Current Leases plummeted 85.76% in 2023, then surged 366.19% in 2025.
  • Year by year, Current Leases stood at $118846.0 in 2021, then increased by 10.63% to $131482.0 in 2022, then crashed by 64.2% to $47069.0 in 2023, then tumbled by 50.38% to $23355.0 in 2024, then surged by 567.63% to $155926.0 in 2025.
  • Business Quant data shows Current Leases for KPRX at $155926.0 in Q3 2025, $143327.0 in Q2 2025, and $71554.0 in Q1 2025.